SEARCH

SEARCH BY CITATION

Literature cited

  • Anderson, K., C. Lutz, F. W. van Delft, C. M. Bateman, Y. Guo, S. M. Colman, H. Kempski et al. 2011. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469:356361.
  • Balak, M. N., Y. Gong, G. J. Riely, R. Somwar, A. R. Li, M. F. Zakowski, A. Chiang et al. 2006. Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors. Clinical Cancer Research 12:64946501.
  • Bardelli, A., D. P. Cahill, G. Lederer, M. R. Speicher, K. W. Kinzler, B. Vogelstein, and C. Lengauer. 2001. Carcinogen-specific induction of genetic instability. Proceedings of the National Academy of Sciences of the United States of America 98:57705775.
  • Beck, B., G. Driessens, S. Goossens, K. K. Youssef, A. Kuchnio, A. Caauwe, P. A. Sotiropoulou et al. 2011. A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 478:399403.
  • Bignell, G. R., C. D. Greenman, H. Davies, A. P. Butler, S. Edkins, J. M. Andrews, G. Buck et al. 2010. Signatures of mutation and selection in the cancer genome. Nature 463:893898.
  • Blasco, M. A. 2005. Telomeres and human disease: ageing, cancer and beyond. Nature Reviews Genetics 6:611622.
  • Cairns, J. 1975. Mutation selection and the natural history of cancer. Nature 255:197200.
  • Chaffer, C. L., I. Brueckmann, C. Scheel, A. J. Kaestli, P. A. Wiggins, L. O. Rodrigues, M. Brooks et al. 2011. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proceedings of the National Academy of Sciences of the United States of America 108:79507955.
  • Chen, J., Y. Li, T.-S. Yu, R. M. McKay, D. K. Burns, S. G. Kernie, and L. F. Parada. 2012. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488:522526.
  • Cicalese, A., G. Bonizzi, C. E. Pasi, M. Faretta, S. Ronzoni, B. Giulini, C. Brisken et al. 2009. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138:10831095.
  • Clappier, E., B. Gerby, F. Sigaux, M. Delord, F. Touzri, L. Hernandez, P. Ballerini et al. 2011. Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. Journal of Experimental Medicine 208:653661.
  • Clark, J., G. Attard, S. Jhavar, P. Flohr, A. Reid, J. De-Bono, R. Eeles et al. 2008. Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene 27:19932003.
  • Clevers, H. 2011. The cancer stem cell: premises, promises and challenges. Nature Medicine 17:313319.
  • Cozzio, A., E. Passegué, P. M. Ayton, H. Karsunky, M. L. Cleary, and I. L. Weissman. 2003. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes and Development 17:30293035.
  • Dawkins, R. 1984. Replicators and vehicles. In R. N. Brandon, and R. Burian, eds. Genes, Organisms, Populations: Controversies Over the Units of Selection. MIT Press, Cambridge, MA.
  • Diaz Jr, L. A., R. T. Williams, J. Wu, I. Kinde, J. R. Hecht, J. Berlin, B. Allen et al. 2012. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486:537540.
  • Dick, J. E. 2008. Stem cell concepts renew cancer research. Blood 112:47934807.
  • Driessens, G., B. Beck, A. Caauwe, B. D. Simons, and C. Blanpain. 2012. Defining the mode of tumour growth by clonal analysis. Nature 488:527530.
  • Dunn, G. P., A. T. Bruce, H. Ikeda, L. J. Old, and R. D. Schreiber. 2002. Cancer immunoediting: from immuno-surveillance to tumor escape. Nature Immunology 3:991998.
  • Eppert, K., K. Takenaka, E. R. Lechman, L. Waldron, B. Nilsson, P. van Galen, K. H. Metzeler et al. 2011. Stem cell gene expression programs influence clinical outcome in human leukemia. Nature Medicine 17:10861093.
  • Gatenby, R. A., and R. J. Gillies. 2008. A microenvironmental model of carcinogenesis. Nature Reviews Cancer 8:5661.
  • Gatenby, R. A., and T. L. Vincent. 2003. An evolutionary model of carcinogenesis. Cancer Research 63:62126220.
  • Gerlinger, M., A. J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez et al. 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine 366:883392.
  • Graham, S. M., H. G. Jørgensen, E. Allan, C. Pearson, M. J. Alcorn, L. Richmond, and T. L. Holyoake. 2002. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to ST1571 in vitro. Blood 99:319325.
  • Greaves, M. 2000. Cancer. The Evolutionary Legacy. Oxford University Press, Oxford.
  • Greaves, M. 2010. Cancer stem cells: back to Darwin? Seminars in Cancer Biology 20:6570.
  • Greaves, M. 2011. Cancer stem cells renew their impact. Nature Medicine 17:10461048.
  • Greaves, M., and C. C. Maley. 2012. Clonal evolution in cancer. Nature 481:306313.
  • Grivennikov, S. I., F. R. Greten, and M. Karin. 2010. Immunity, inflammation, and cancer. Cell 140:883899.
  • Gupta, P. B., C. L. Chaffer, and R. A. Weinberg. 2009. Cancer stem cells: mirage or reality? Nature Medicine 15:10101012.
  • Gupta, P. B., C. M. Fillmore, G. Jiang, S. D. Shapira, K. Tao, C. Kuperwasser, and E. S. Lander. 2011. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146:633644.
  • Hanahan, D., and R. A. Weinberg. 2011. Hallmarks of cancer: the next generation. Cell 144:646674.
  • Ishizawa, K., Z. A. Rasheed, R. Karisch, Q. Wang, J. Kowalski, E. Susky, K. Pereira et al. 2010. Tumor-initiating cells are rare in many human tumors. Cell Stem Cell 7:279317.
  • Isoda, T., A. M. Ford, D. Tomizawa, F. W. Van Delft, D. Gonzalez De Castro, N. Mitsuiki, J. Score et al. 2009. Immunologically silent cancer clone transmission from mother to offspring. Proceedings of the National Academy of Sciences of the United States of America 106:1788217885.
  • Koh, M. Y., R. Lemos Jr, X. Liu, and G. Powis. 2011. The hypoxia-associated factor switches cells from HIF-1a- to HIF-2a-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. Cancer Research 71:40154027.
  • Lane, S. W., D. T. Scadden, and D. G. Gilliland. 2009. The leukemic stem cell niche - current concepts and therapeutic opportunities. Blood 114:11501157.
  • Levin, B. R., and J. J. Bull. 1994. Short-sighted evolution and the virulence of pathogenic microorganisms. Trends in Microbiology 2:7681.
  • Lewontin, R. C. 1970. The units of selection. Annual Review of Ecology and Systematics 1:118.
  • Malanchi, I., A. Santamaria-Martínez, E. Susanto, H. Peng, H.-A. Lehr, J.-F. Delaloye, and J. Huelsken. 2012. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481:8589.
  • Merlo, L. M. F., J. W. Pepper, B. J. Reid, and C. C. Maley. 2006. Cancer as an evolutionary and ecological process. Nature Reviews Cancer 6:924935.
  • Merlos-Suárez, A., F. M. Barriga, P. Jung, M. Iglesias, M. Virtudes Céspedes, D. Rossell, M. Sevillano et al. 2011. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8:511524.
  • Michod, R. E. 1999. Darwinian Dynamics: Evolutionary Transitions in Fitness and Individuality. Princeton University Press, Princeton.
  • Mullighan, C. G., L. A. Phillips, X. Su, J. Ma, C. B. Miller, S. A. Shurtleff, and J. R. Downing. 2008. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322:13771380.
  • Murchison, E. P. 2009. Clonally transmissible cancers in dogs and Tasmanian devils. Oncogene 27:S19S30.
  • Murgia, C., J. K. Pritchard, S. Y. Kim, A. Fassati, and R. A. Weiss. 2006. Clonal origin and evolution of a transmissible cancer. Cell 126:477487.
  • Navin, N., J. Kendall, J. Troge, P. Andrews, L. Rodgers, J. McIndoo, K. Cook et al. 2011. Tumour evolution inferred by single-cell sequencing. Nature 472:9094.
  • Nik-Zainal, S., P. Van Loo, D. C. Wedge, L. B. Alexandrov, C. D. Greenman, K. W. Lau, K. Raine et al.; Breast Cancer Working Group of the International Cancer Genome Consortium Cell. 2012. The life history of 21 breast cancers. Cell 149:9941007.
  • Notta, F., C. G. Mullighan, J. C. Wang, A. Poeppl, S. Doulatov, L. A. Phillips, J. Ma et al. 2011. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 469:362367.
  • Nowak, M. A., F. Michor, and Y. Iwasa. 2003. The linear process of somatic evolution. Proceedings of the National Academy of Sciences of the United States of America 100:1496614969.
  • Nowell, P. C. 1976. The clonal evolution of tumor cell populations. Science 194:2328.
  • O'Brien, C. A., A. Kreso, and C. H. M. Jamieson. 2010. Cancer stem cells and self-renewal. Clinical Cancer Research 16:31133120.
  • Okasha, S. 2006. Evolution and the Levels of Selection. Clarendon Press, Oxford.
  • Pienta, K. J., N. McGregor, R. Axelrod, and D. E. Axelrod. 2008. Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. Translational Oncology 1:158164.
  • Podlaha, O., M. Riester, S. De, and F. Michor. 2012. Evolution of the cancer genome. Trends in Genetics 28:155163.
  • Quintana, E., M. Shackleton, M. S. Sabel, D. R. Fullen, T. M. Johnson, and S. J. Morrison. 2008. Efficient tumour formation by single human melanoma cells. Nature 456:593598.
  • van Rhenen, A., N. Feller, A. Kelder, A. H. Westra, E. Rombouts, S. Z. Weegman, M. A. van der Pol et al. 2005. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clinical Cancer Research 11:65206527.
  • Ridley, M. 2003. Evolution, 3rd edn. Blackwell Science, Cambridge, MA.
  • Roche-Lestienne, C., J.-L. Laï, S. Darré, T. Facon, and C. Preudhomme. 2003. A mutation conferring resistance to imatinib at the time of diagnosis of chronic myelogenous leukemia. New England Journal of Medicine 348:22652266.
  • Rosen, J. M., and C. T. Jordan. 2009. The increasing complexity of the cancer stem cell paradigm. Science 324:16701673.
  • Sarry, J.-E., K. Murphy, R. Perry, P. V. Sanchez, A. Secreto, C. Keefer, C. R. Swider et al. 2011. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rgc-deficient mice. Journal of Clinical Investigation 121:384395.
  • Shackleton, M., E. Quintana, E. R. Fearon, and S. J. Morrison. 2009. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138:822829.
  • Shah, N. P., J. M. Nicoll, B. Nagar, M. E. Gorre, R. L. Paquette, J. Kuriyan, and C. L. Sawyers. 2002. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell 2:117125.
  • Skloot, R. 2010. The Immortal Life of Henrietta Lacks. Random House, New York.
  • Sober, E., and D. S. Wilson. 1994. A critical review of philosophical work on the units of selection problem. Philosophy of Science 61:534555.
  • Stratton, M. R., P. J. Campbell, and P. A. Futreal. 2009. The cancer genome. Nature 458:719724.
  • Vago, L., S. K. Perna, M. Zanussi, B. Mazzi, C. Barlassina, M. T. L. Stanghellini, N. F. Perrelli et al. 2009. Loss of mismatched HLA in leukemia after stem-cell transplantation. New England Journal of Medicine 361:478488.
  • Visvader, J. E. 2011. Cells of origin in cancer. Nature 469:314322.
  • Williams, G. C. 1966. Adaptation and Natural Selection. Princeton University Press, Princeton, New Jersey.
  • Williams, G. C. 1992. Natural Selection: Domains, Levels, Challenges. Oxford University Press, Oxford.
  • Wu, X., P. A. Northcott, A. Dubuc, A. J. Dupuy, D. J. H. Shih, H. Witt, S. Croul et al. 2012. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 482:529533.
  • Yachida, S., S. Jones, I. Bozic, T. Antal, R. Leary, B. Fu, M. Kamiyama et al. 2010. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467:11141117.
  • Yates, L. R., and P. J. Campbell. (2012). Evolution of the cancer genome. Nature Reviews Genetics doi:10.1038/ncg3317 [Epub ahead of print].
  • Youn, A., and R. Simon. 2011. Identifying cancer driver genes in tumor genome sequencing studies. Bioinformatics 27:175181.